Sudha Rao
Tracked across 1 events · 7 articles · First seen Jul 20, 2026 · Last active Sep 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Sudha Rao, Chief Scientific Officer, is a key spokesperson and likely a driver of the scientific strategy behind paxalisib's development.
Jul 20, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Sudha Rao live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard